We started lower this morning which is not that bad. I think if we rallied off the start then we likely give it up but a dip to flush out the frustrated traders (and let us be honest that is all of us at this point) might clear the deck for a really rally later […]
November 10th Biotech Update
Guess what, the sector remains range bound. We approached the upper end of the range and it was a pretty quick move to the upper end of the range but now we are pulling back. I thought there was a chance that the sector would get closer to the upper end of the range before […]
November 8th Biotech Update
We remain range bound with some weakness to end last week and some indecision to start this week. I still think we make a move to the upper end of this range at some point and I do not think the first attempt to breakout will be successful. It is possible but my running assumption […]
July 7th Biotech Update
The broader market did not help yesterday but we certainly did not ruin the potential uptrend but we did nothing to confirm it either. I think another decent sized down day today would be a problem but we have almost been straight down the past week so a snap back rally would not be a […]
June 19th Biotech Update
I think the sector is setting up well if we can break above the $138 level in the near term. Yes, we had a couple days of weakness earlier this week but the recent strength (modest as it has been) is setting up that weakness as a potential higher low. This become more likely if […]
May 28th Biotech Update
We have had 3 green days in a row (assuming that today remains green). This is sadly the best the sector has done in awhile. If you look really hard you can see a mini uptrend with this being the first higher high after a higher low. I call it mini as it is still […]
May 26th Biotech Update
I almost feel like we are stuck in a no news period until earnings but then I remember that we still have ASCO coming up (even though I am not sure it will provide very many fireworks for the sector). I have been talking about the sector being potentially in a trading zone but it […]
May 10th Biotech Update
Not a great start to the week and not a lot of reasons to explain it. There is really no big news out this morning and perhaps that is part of the issue. With the narrative and sentiment already negative a day without anything positive is going to generally be weak. The big earnings have […]
April 26th Biotech Update
An OK start to the week in terms of being green. It looks like we have broken the lower high trends and it would be great to get confirmation of that this week and even make a push at $140 in the XBI. I know it is easy to dump on the sector but honestly […]
April 16th Biotech Update
Today is modestly important not that we are going to break above an important range or below one but continued momentum higher is sort of key. We have had a good week so do far but if we stall at these levels it really looks like a clear trend line lower where yesterday has the […]
April 7th Biotech Update
We remain mired in the middle with nothing really to signal the ultimate resolution of this situation. I would simply remain focused on the fundamentals of companies and simply be aware that the broader sector will at some point clarify the next move. I would be ready for a move higher or lower as I […]
March 12 Biotech (and Energy) Update
I think the only thing we can say with confidence is that we are in the middle of process as there is not clear uptrend, downtrend or bottom. This makes for frustrating moves for both bears and bulls as what looks good for your view on day is not another day (in fact it seems […]
February 19th Biotech Update
The sector really seems unable to bounce which seems to open up a move to $150. That being said I really think we are oversold in the near term and so it would really be a signal of disinterest in the sector if we continue to $150. In some ways, it sets up a pretty […]
January 27th Biotech Update
The market is a little odd right now. We are near or at highs and markets at these levels tend to continue higher. Ultimately they will correct and while the moves higher tend to look like grinds, the corrections are fast. What makes the market odd to interpret right now is that we are getting […]
January 25th Biotech Update
The week starts as last week ending which is quiet. We are starting to get earnings this week which will pick up the news flow but it is not really into next week that the biotech earnings starting hitting in earnest. This week we generally are getting some large pharma which will help us get […]
January 22nd Biotech Update
Not much happening as seems to be the theme of the week. Perhaps I had some wishful thinking that earnings will kick off at the end of January but it does seem like the first week of February will be the week where it kicks into high gear. As such I would expect another slow […]
January 20th Biotech Update
So the page has turned from JPM and next is earnings and the usual rush of secondaries. Remember, however, that we had lot of secondaries to end the year, so perhaps the end of January will not be as flush with cash raising as in previous years. Earnings will likely be a little anti-climatic as […]
January 15th Biotech Update
So JPM is done and it was the least eventful one I can remember. I am still a little surprised that the sector has done this well. Usually post JPM we see a flood of secondaries and I suspect there will be an uptick in the next couple weeks. That being said we ended last […]
December 1st Biotech Update
A strong start to the week that is continuing. While certain sentiment measures are getting into danger territory, it still seems like the market has a little bit more room for running. The uncertainty around the elections is waning and the Biden economic team seems to indicate a strong desire for fiscal stimulus. We are […]
November 20th Biotech Update
I think choppy might have been the best description of the market at this point. This makes sense give the competing influences on both the market and economy. I would not be surprised to see this chop continue or perhaps even see some consolidation. The broader market seems in a little more precarious position than […]
